Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in PHVS — Pharvaris N.V.

CIK 1446194 BALA CYNWYD, PA

Position in PHVS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$629,425
-$641,090 QoQ
Shares Held
18,202
-59.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 124 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PHVS Over Time

Shares Held

Position Value (USD)

Derivatives in PHVS

reported options exposure · as of Jun 30, 2026
CallValue
$594,776
CallShares
17,200
PutValue
$1,186,094
PutShares
34,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. PHVS ranks #152 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PHVS

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $594,776 17,200
2026-06-30 $629,425 18,202
2026-06-30 $1,186,094 34,300
2026-03-31 $1,180,850 41,800
2026-03-31 $1,270,515 44,974
2025-12-31 $1,710,066 61,624
2025-12-31 $1,667,775 60,100